Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03255083
Title DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Daiichi Sankyo, Inc.
Indications

lung non-small cell carcinoma

lung adenocarcinoma

Therapies

DS-1205c + Osimertinib

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Taipei Medical University, Shuang Ho Hospital New Taipei City 23561 Taiwan Details
China Medical University Hospital Taichung 40447 Taiwan Details
Taichung Veterans General Hospital Taichung 40705 Taiwan Details
National Cheng-Kung University Hospital Tainan 70457 Taiwan Details
National Taiwan University Hospital Taipei 10048 Taiwan Details
Taipei Medical University Hospital Taipei 11031 Taiwan Details
Taipei Veterans General Hospital Taipei 11217 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field